agingbiomarkers.com
October 2013 | Aging Diagnostics
http://www.agingbiomarkers.com/2013_10_01_archive.html
Young scientist's quest to defeat aging. Monday, October 21, 2013 By DNAmite. It is a pleasure to see someone truly dedicated to defeating aging through excellence in scientific research. We would like to wish her all the best in her endeavors. A team of Russian scientists drills into the problem of age-related mineralization of the connective tissue. Tuesday, October 1, 2013 By DNAmite. The many factors leading to mineralization of the connective tissue include genetic and acquired diseases, inflammatio...
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: April 2009
http://drugdiscoverywizzards.blogspot.com/2009_04_01_archive.html
Drug Discovery with Quantum Pharmaceuticals. Monday, April 6, 2009. Molecular polarization on a polar liquid interface: the structure of a water surface. The orientations of water molecules within the liquid depend on interplay of long-range dipole-dipole interaction and short range hydrogen-bonding interactions. At room temperature water is in paraelectric (disordered) phase and thus average dipole moment of any large enough fraction of the liquid vanishes. The second graph corresponds to the polarizati...
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: The nature of phospholipid membranes repulsion at nm-distances
http://drugdiscoverywizzards.blogspot.com/2009/08/nature-of-phospholipid-membranes.html
Drug Discovery with Quantum Pharmaceuticals. Monday, August 31, 2009. The nature of phospholipid membranes repulsion at nm-distances. Why hydrophobic membranes repel at small distances? More details can be found here:. The nature of phospholipid membranes repulsion at nm-distances. Peter Fedichev (Quantum CTO). I found this site using [url=http:/ google.com]google.com[/url] And i want to thank you for your work. You have done really very good site. Great work, great site! November 8, 2009 at 5:17 PM.
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: Molecular polarization on a polar liquid interface: the structure of a water surface
http://drugdiscoverywizzards.blogspot.com/2009/04/molecular-polarization-on-polar-liquid.html
Drug Discovery with Quantum Pharmaceuticals. Monday, April 6, 2009. Molecular polarization on a polar liquid interface: the structure of a water surface. The orientations of water molecules within the liquid depend on interplay of long-range dipole-dipole interaction and short range hydrogen-bonding interactions. At room temperature water is in paraelectric (disordered) phase and thus average dipole moment of any large enough fraction of the liquid vanishes. The second graph corresponds to the polarizati...
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: August 2008
http://drugdiscoverywizzards.blogspot.com/2008_08_01_archive.html
Drug Discovery with Quantum Pharmaceuticals. Wednesday, August 20, 2008. Quantum LogP module (part of q-Mol package) has been benchmarked by vcclab.org. Quantum LogP module (part of q-Mol package) has been reviewed by R. Mannhold et al. (vcclab.org) in "Calculation of Molecular Lipophilicity: State-of-the-Art and Comparison of Log P Methods on More Than 96,000 Compounds". Peter Fedichev (Quantum CTO). Monday, August 18, 2008. 4 pages, 1 eps figure. Statistical Mechanics (cond-mat.stat-mech).
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: August 2009
http://drugdiscoverywizzards.blogspot.com/2009_08_01_archive.html
Drug Discovery with Quantum Pharmaceuticals. Monday, August 31, 2009. The nature of phospholipid membranes repulsion at nm-distances. Why hydrophobic membranes repel at small distances? More details can be found here:. The nature of phospholipid membranes repulsion at nm-distances. Peter Fedichev (Quantum CTO). Subscribe to: Posts (Atom). Subscribe to Drug Discovery with Quantum Pharmaceuticals by Email. Mechanism of action exploration. Peter Fedichev (Quantum CTO). Quantum Pharmaceuticals Suggested Links.
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: June 2009
http://drugdiscoverywizzards.blogspot.com/2009_06_01_archive.html
Drug Discovery with Quantum Pharmaceuticals. Saturday, June 20, 2009. HERG binding correlates with LogP? Here is a very good analysis from human ERG blockers article. The plot below (created using Vortex. Shows pIC50 calculated from the literature IC50 data versus calculated logP determined using alogPS. The colour coding shows the overall general tend of increasing hERG activity as logP increases, it also highlights the reduced liability seen with acids (green) and zwitterions (red).
drugdiscoverywizzards.blogspot.com
Drug Discovery with Quantum Pharmaceuticals: June 2008
http://drugdiscoverywizzards.blogspot.com/2008_06_01_archive.html
Drug Discovery with Quantum Pharmaceuticals. Sunday, June 15, 2008. Quantum Pharmaceuticals announce collaboration with University of Colorado at Boulder. Moscow, July 15 2008. Quantum Pharmaceuticals is a drug discovery company based in Moscow, Russia specializing in small molecule screening and design through the use of its proprietary technology platform. Friday, June 6, 2008. Docking validation study: PDK1-kinase (oncology). Following the classic thrombine study. Also known as PDK1. Is a human gene.
agingcell.com
Aging Cell - Novel strategies for combating aging: October 2013
http://www.agingcell.com/2013_10_01_archive.html
Aging Cell - Novel strategies for combating aging. The purpose of this website is to discuss various theories of aging and evaluate several strategies for slowing down the aging processes. The first strategy to be evaluated is the selective fortification of organic compounds with heavier isotopes of carbon (13C) and hydrogen (deuterium). The isotope effect will create more stable chemical bonds and reduce the effects of oxidative stress on amino acids, lipids and nucleic acids. Monday, October 21, 2013.
